US · DH
Definitive Healthcare Corp.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Framingham, MA 01701
- Website
- definitivehc.com
Price · as of 2025-12-31
$0.99
Market cap 132.23M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $24.58 | +2,392.4% |
| Intrinsic Value(DCF) | $1.62 | +64.27% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $19.85 | $39.31 | $1.33 | $0.00 | $0.00 |
| 2022 | $11.03 | $34.46 | $2.58 | $0.00 | $0.00 |
| 2023 | $8.48 | $23.91 | $0.00 | $0.00 | $0.00 |
| 2024 | $2.85 | $17.58 | $0.00 | $0.00 | $0.00 |
| 2025 | $1.14 | $24.58 | $1.93 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Definitive Healthcare Corp.'s (DH) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $24.58
- Current price
- $0.99
- AI upside
- +2,392.4%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.62
+64.27% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| DH | Definitive Healthcare Cor… | $0.99 | 132.23M | +2,392% | +64% | — | — | -0.61 | 0.32 | 0.50 | 0.32 | — | -1.85 | 75.88% | -8.52% | -57.52% | -48.41% | -6.39% | -21.84% | 0.02 | -1.82 | 1.64 | 1.49 | 0.96 | -6328.00% | -424.00% | -1918.00% | 30.48% | 0.34 | 12.09% | 0.00% | 0.00% | 290.32% | 2.50 | -1.39 | -0.21 | 0.60 |
| CABA | Cabaletta Bio, Inc. | $3.32 | 319.6M | — | — | — | — | -0.79 | 0.60 | — | 0.51 | -1.89 | 0.60 | 0.00% | — | — | -59.64% | -6352.34% | -52.82% | 0.10 | -167.30 | 6.15 | 6.05 | 1.35 | 4182.00% | — | 6674.00% | -98.71% | -3.26 | -4590.51% | 0.00% | 0.00% | 0.00% | 0.45 | 0.63 | — | -2.29 |
| EDIT | Editas Medicine, Inc. | $2.20 | 214.76M | +883% | +13% | — | +6,172% | -0.60 | 1.05 | 4.38 | 0.40 | -1.40 | 1.05 | 100.00% | -777.22% | -733.72% | -98.10% | 1925.86% | -56.40% | 0.26 | — | 3.75 | 3.71 | 0.41 | 4257.00% | -5864.00% | 6005.00% | -154.71% | -2.72 | 1680.16% | 0.00% | 0.00% | 15.11% | 0.37 | 0.43 | -2.89 | -7.20 |
| KYTX | Kyverna Therapeutics, Inc… | $8.21 | 359.53M | — | — | — | — | -0.78 | 0.37 | — | 1.42 | 0.00 | 0.37 | 0.00% | — | — | -80.74% | 2732.66% | -67.12% | 0.03 | -1004.25 | 8.61 | 8.47 | 0.71 | 332990000.00% | — | 11960.00% | -116.84% | -3.38 | 2231.58% | 0.00% | 0.00% | 63.02% | 1.25 | 1.53 | — | -0.17 |
| NAKA | Nakamoto Inc. | $0.25 | 92.19M | +34,449% | +169% | — | +4,954% | -2.46 | 3.46 | 3.27 | -2.47 | -1.66 | 4.08 | 96.96% | -123.05% | -133.01% | -294.13% | -619.29% | -151.45% | 0.31 | -8.51 | 4.13 | 3.81 | 0.50 | 14815.00% | -2783.00% | 64918.00% | -39.07% | -5.07 | -643.12% | 0.00% | 0.00% | 18.24% | -2.21 | -2.13 | 2.72 | 0.21 |
| NRC | National Research Corpora… | $13.41 | 303.84M | +162% | -57% | — | -83% | 26.72 | 22.16 | 2.26 | 12.73 | — | -5.94 | 56.33% | 16.44% | 8.44% | 51.24% | 16.29% | 8.68% | 5.65 | 4.74 | 0.55 | 0.42 | 2.48 | -5000.00% | -396.00% | -1790.00% | 5.08% | 0.72 | 17.46% | 3.54% | 94.60% | 10.05% | 17.04 | 24.45 | 2.80 | 2.78 |
| OMI | Owens & Minor, Inc. | $2.68 | 207.07M | +942% | +49% | — | — | -2.12 | 1.36 | 0.07 | 48.40 | -0.28 | -0.72 | 20.74% | -1.94% | -3.39% | -48.70% | -7.35% | -7.44% | 3.79 | -1.44 | 1.08 | 0.39 | 35.40 | 76000.00% | 355.00% | -11251.00% | -8.69% | 0.09 | -2.36% | 0.00% | 0.00% | 0.00% | -13.75 | -42.87 | 0.27 | 2.30 |
| SLP | Simulations Plus, Inc. | $12.23 | 246.39M | +509% | -44% | — | — | -5.32 | 2.76 | 4.35 | 21.26 | — | 6.64 | 58.38% | -89.33% | -81.74% | -42.13% | -51.50% | -38.12% | 0.00 | — | 7.67 | 6.98 | -2.06 | -75714.00% | 1309.00% | 3653.00% | 5.06% | 2.70 | 13.59% | 0.00% | 0.00% | 6.08% | -4.42 | 17.95 | 3.95 | 27.83 |
| SOPH | SOPHiA GENETICS S.A. | $4.50 | 305.31M | +461% | -71% | — | — | -3.48 | 2.21 | 3.27 | -3.21 | — | 3.16 | 67.42% | -102.14% | -95.89% | -49.42% | -143.02% | -33.90% | 0.31 | -34.80 | 3.71 | 3.32 | 0.99 | -2213.00% | 449.00% | -1177.00% | -23.93% | -1.60 | -109.57% | 0.00% | 0.00% | 0.00% | -2.45 | -3.19 | 2.50 | -2.23 |
| SPOK | Spok Holdings, Inc. | $12.14 | 250.06M | +169% | -47% | — | -40% | 15.71 | 1.70 | 1.79 | 9.30 | 573.54 | 5.29 | 78.84% | 14.11% | 11.37% | 10.55% | 11.13% | 7.50% | 0.05 | — | 1.18 | 0.98 | -0.74 | 274.00% | 149.00% | -201.00% | 10.10% | 0.59 | 19.20% | 10.92% | 171.60% | 11.94% | 11.73 | 9.18 | 1.65 | 3.82 |
| TBRG | TruBridge, Inc. | $19.29 | 289.52M | +494% | -41% | — | — | -19.81 | 2.40 | 1.18 | 16.24 | — | -3.32 | 50.81% | 1.94% | -5.97% | -11.59% | 1.86% | -4.95% | 1.04 | 0.41 | 1.70 | 1.34 | 4.65 | -5619.00% | 95.00% | -15833.00% | 3.22% | 0.61 | 3.65% | 0.00% | 0.00% | 9.23% | 85.50 | 43.52 | 1.66 | 2.06 |
About Definitive Healthcare Corp.
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
- CEO
- Kevin D. Coop
- Employees
- 782
- Beta
- 1.59
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.62 ÷ $0.99) − 1 = +64.27% (DCF, example).